Wi kin ɔndastand se fɔ yɛri di wɔd “ Lukimia ” kin mek yu fred. Na nɔmal tin fɔ lɛ pɔsin wɔri we yu de gɛt dɛn kayn tin dɛn ya. Bɔt fɔ ɔndastand gud gud wan wetin i bi, wetin mek i kin apin, wetin de sho se i gɛt di sik, ɛn fɔ no se fayn tritmɛnt dɛn de, dat kin ɛp fɔ mek dɛn fred dɛn de nɔ bɔku. Na Nirogi Lanka, wi want fɔ tɔk bɔt dis kansa we gɛt fɔ du wit blɔd insay wan simpul we we pɔsin kin tɔk bɔt—jɔs lɛk aw yu padi ɔ yu fambul kin ɛksplen am to yu.
Wetin na Lukimia?
Fɔ tɔk am simpul wan, lukimiya na kansa we de na di blɔd . Di men faktri fɔ mek blɔd na yu bɔdi na yu bon mɛro . insay dis "faktri," yu bכdi de stat fכ prodyuz abnכmal bכdi sεl dεm — spεshal wan wayt blכd sεl dεm we nכ machכ — we nכ de kכntrol. Dɛn pul di wɔd “lukimiya” frɔm di Grik wɔd dɛn fɔ “wayt” (leukos) ɛn “blɔd” (haima).
Nɔ lɛk bɔku ɔda kansa dɛn , lukimiya nɔ kin mek wan sɔlid mas ɔ (tumor) we yu go si pan X-ray ( X-ray ) ɔ CT skan ( CT scan ).
Bɔku kayn lukimiya de. Sɔm kin apin mɔ pan pikin dɛn, ɛn ɔda wan dɛn kin bɔku pan big pipul dɛn. Di tritmɛnt disizhɔn dɛn kin rili difrɛn bay di patikyula kayn lukimiya, yu ej, ɛn yu ɔl yu wɛlbɔdi stet.
Aw lukimiya kin kam?
Lukimia kin bigin na yu bon mכro , we na di saf sכft tisu we lεk spɔnj insay yu bon dεm. Na dis say yu bɔdi de mek blɔd sɛl dɛn. Dɛn sɛl dɛn ya kin du bɔku tin dɛn fɔ mek dɛn machɔ gud gud wan. Tri men kayn blɔd we gɛt wɛlbɔdi:
- Rɛd blɔd sɛl dɛn : Dɛn wan ya kin kɛr ɔksijɛn ɛn ɔda impɔtant tin dɛn ɔlsay na yu bɔdi.
- Wait blɔd sɛl : Dɛn wan ya na yu imyun sistɛm in difɛns tim, we de fɛt di infɛkshɔn.
- Plɛtlɛt : Dɛn tin ya kin ɛp fɔ mek yu blɔd klɔt we yu gɛt injuri.
כl dεn sεl dεm ya kכmכt frכm εmatopoiεtik stεm sεl dεm. dis stεm sεl dεm de branch insay tu rod dεm: mayloid sεl dεm εn limfoyd sεl dεm. We dɛn de divɛlɔp nɔmal wan, dɛn kin bi:
- Mayloid sel dεm : we de mek rεd bכdi sεl dεm, pletlet dεm, εn sכm wayt blכd sεl dεm (Basophils, Eosinophils , εn Neutrophils).
- limfoyd sεl dεm : we de mek כda wayt bכdi sεl dεm (Lymphocytes and Natural killer cells).
Insay pɔsin we gɛt lukimiya, wan pan dɛn sɛl ya we de divɛlɔp kin bigin fɔ sheb kwik kwik wan ɛn i nɔ kin ebul fɔ kɔntrol am . Wi kin kɔl dɛn tin ya “lukimiya sɛl dɛn.” Dɛn kin krawd di bon mɛro, ɛn dɛn nɔ kin lɛf ples fɔ mek dɛn gɛt wɛlbɔdi rɛd blɔd sɛl dɛn, wayt blɔd sɛl dɛn, ɔ pletlɛt dɛn.
Aw lukimiya kin afɛkt yu bɔdi?
We di lukimiya sɛl dɛn pas di sɛl dɛn we gɛt wɛlbɔdi, sɔm prɔblɛm dɛn kin apin:
- Lukimia sɛl dɛn nɔ de du di impɔtant wok dɛn we wɛlbɔdi sɛl dɛn de du.
- Bikɔs di lukimiya sɛl dɛn kin krawd di bon mɛro, di sɛl dɛn we gɛt wɛlbɔdi nɔ kin ebul fɔ gro ɔ machɔ fayn .
- Dis kin mek yu bɔdi nɔ ebul fɔ mek rɛd sɛl dɛn, wayt sɛl dɛn, ɔ pletlɛt dɛn we de wok fayn.
- So, yu ɔgan ɛn tisu dɛn nɔ go gɛt bɛtɛ ɔksijɛn. Apat frɔm dat, yu bɔdi nɔ kin ebul fɔ fɛt di infɛkshɔn ɔ i kin mek yu blɔd klɔt fayn fayn wan if yu wund.
Wetin na di men kayn lukimiya?
jεnarali dεn kin kכl lukimiya bay aw fast i de go bifo εn us sεl layn (mayloid כ lymphoid) de afekt.
Na bay we di sik de go bifo kwik kwik wan
- Akyu lukimiya : Insay dis kayn lukimiya, di lukimiya sɛl dɛn kin bɔku kwik kwik wan, we kin mek di sik go bifo kwik kwik wan. Yu kin bigin fɔ fil bad insay sɔm wiks. Dis na mɛdikal imejensi we nid fɔ gɛt tritmɛnt kwik kwik wan. Na di kayn kansa we kin kam pan pikin dɛn.
- Krכnik lukimiya : Insay dis kayn, sכm sεl dεm nכ de machכ we כda wan dεm de bihayv mכr lεk machכ sεl dεm. Dɛn kin du sɔm wok dɛn, pan ɔl we dɛn nɔ kin du fayn lɛk di sɛl dɛn we gɛt wɛlbɔdi. Dis sik de go bifo sloslo pas akyu lukimiya. Yu kin liv fɔ lɔng lɔng tɛm ɛn nɔr kin gɛt sɔm kayn sik. Dis kin apin mɔ pan big pipul dɛn pas pikin dɛn.
Bay di kayn sɛl we dɛn gɛt
- Myelogenous or Myeloid leukemia : I de afɛkt di myeloid sel dɛm, we de mek rɛd blɔd sɛl dɛm, pletlɛt dɛm, ɛn sɔm wayt blɔd sɛl dɛm.
- Limfosaytik lukimiya : I de afɛkt di limfoyd sɛl dɛn, we rili impɔtant fɔ yu imyun sistɛm.
Fo men kayn lukimiya
We wi jɔyn dɛn klasification ya, 4 praymar kayn dɛn de:
1. Acute Lymphocytic Leukemia (ALL) : Na di kayn we we kin kɔmɔn pas ɔl pan pikin ɛn yɔŋ pipul dɛn (we kin rich 39 ia), pan ɔl we i kin afɛkt ɛni ej grup.
2. Acute Myelogenous Leukemia (AML) : Na di akyu tכp we kin kכmכn pan big pipul dεm, spεshal wan dεm we pas 65 ia, pan כl we i kin apin bak pan pikin dεm.
3. Kronik Limfosaytik Lukimiya (CLL) : Na di kayn kronik we kin kכmכn pan big pipul dεm (patikul di wan dεm we pas 65 ia). I kin tek sɔm ia fɔ mek di sik sho.
4. Chronic Myelogenous Leukemia (CML) : I kin apin mɔ pan ol pipul dɛn (especially ova 65 ia), pan ɔl we i kin apin to ɛni big pɔsin. I nɔ kin bɔku pan pikin dɛn ɛn i kin tek sɔm ia fɔ mek dɛn gɛt di sik.
Aw kɔmɔn sik we dɛn kɔl lukimiya?
Statistikin sho se lukimiya de pan di tɛn kansa dɛn we kin bɔku. Pan ɔl we ɛnibɔdi kin gɛt am, sɔm grup dɛn kin gɛt mɔ prɔblɛm:
- Pipul dɛn we ol 65 to 74 ia.
- Man dɛn.
- Sɔm trayb dɛn.
Bɔku pipul dɛn biliv se lukimiya na jɔs wan sik we dɛn kin gɛt we dɛn smɔl. Bɔt bɔku pan di kayn dɛn kin rili bɔku pan big pipul dɛn. Pan ɔl we lukimiya nɔ kin bɔku pan pikin dɛn, i stil bi di kansa we dɛn kin no mɔ pan pikin dɛn ɛn yɔŋ pipul dɛn.
Wetin na di sayn dɛm wae de sho se yu gɛt lukimiya?
Di sayn dɛm fɔ lukimiya de dipen pan di patikyula kayn wae yu gɛt. Fɔ ɛgzampul, if yu gɛt krɛse sik, yu nɔ go gɛt ɛni impɔtant sayn dɛn we yu bigin fɔ gɛt.
Na sɔm pan de sayn ɛn sayn dɛm wae de sho se yu gɛt lukimiya:
- Fɔ taya ɔltɛm ɔ fɔ fil lɛk se yu taya izi wan.
- Fiva ɔ swet na nɛt .
- Infekshɔn dɛn we kin kam bɔku tɛm .
- Di shɔt we aw yu de blo .
- Pale skin .
- We yu de lɔs yu wet we yu nɔ ɛksplen .
- Bon ɔ jɔyn kin pen ɔ we yu tɔch yu.
- Filin fɔ pen ɔ ful ɔnda yu lɛft rib.
- Di limf no dɛm we dɔn swel na yu nɛk, yu armpit, ɔ yu groin, ɔ yu splin ɔ liva we dɔn big.
- I izi fɔ brus ɛn blɔd , lɛk fɔ blɔd na yu nos, blɔd na yu gɔm, smɔl smɔl rɛd spat dɛn na yu skin (petechiae), ɔ pepul/blak pat dɛn we yu nɔ ɛksplen.
If yu gɛt ɛni wan pan dɛn sik ya, i nɔ min se yu gɛt lukimiya. Bɔt if yu de gɛt dɛn sayn ya, i rili impɔtant fɔ mek yu go to dɔktɔ fɔ mek dɛn chɛk yu.
Wetin kin mek pɔsin gɛt lukimiya?
Lukimia kin bigin wit wan jεnεtik mכtεshכn na di DNA fכ wan sεl insay yu bon mכro. DNA de wok lɛk wan sɛt ɔf instrɔkshɔn, we de tɛl di sɛl ustɛm fɔ gro, aw fɔ wok, ɛn ustɛm fɔ day.
Bikɔs ɔf dis muteshon, di lukimiya sɛl dɛn kin bigin fɔ bɔku we dɛn nɔ ebul fɔ kɔntrol. εvri sεl we dεn mek frכm da כrijinal mכtayt sεl de go kכri di sem abnכmal DNA.
Pan ɔl we sayɛnsman dɛn nɔ no yet bɛtɛ bɛtɛ wan wetin mek dɛn chenj ya kin apin, dɛn dɔn no sɔm kɔmɔn chenj dɛn we gɛt fɔ du wit difrɛn kayn lukimiya.
Udat dɛn kin gɛt bɔku risk fɔ gɛt lukimiya?
Ɛnibɔdi kin gɛt lukimiya, bɔt risach dɔn sho se sɔm tin dɛn kin mek yu gɛt mɔ sik, lɛk:
- Tritmɛnt fɔ kansa bifo : If yu dɔn gɛt tritmɛnt lɛk redyushɔn tɛrapi ɔ kemotɛrapi, yu kin gɛt bɔku risk fɔ gɛt sɔm kayn lukimiya.
- Smok : If yu de smok ɔ yu de smok sɛkɔn-han smok, yu risk fɔ gɛt akyu mayloid lukimiya (AML) go bɔku.
- Eksposhɔn to industrial kεmikכl : Kεmikכl dεm lεk bεnzin εn fכmaldehayd na tin dεm we dεn no se de mek kansa. Yu kin fɛn dɛn tin ya na di tin dɛn we dɛn kin yuz fɔ bil ɛn difrɛn tin dɛn we dɛn kin yuz na os (plastik, rɔba, pent, peshɛnt sayd, mɛrɛsin, ditajɛn, sop, ɛn shampoo).
- Sɔm jɛnɛtik kɔndishɔn : Jɛnɛtik dizayd lɛk Nyurofibromatosis, Klinefelter syndrome, Schwachman-Diamond syndrome, ɛn Down syndrome kin mek yu gɛt mɔ risk.
- Famili istri : Risach dɔn sho se sɔm kayn lukimiya kin gɛt sɔntin we pɔsin kin gɛt frɔm in mama ɛn papa. Bɔt if yu gɛt pɔsin na yu famili we gɛt lukimiya, dat nɔ min se yu go rili gɛt am. Ɔltɛm tɛl yu dɔktɔ if i dɔn gɛt kansa ɔr yu famili gɛt prɔblɛm wit yu jɛnɛtik; dɛn kin rεkomεnd fɔ du jεnεtik tεst fɔ asɛs yu pasɔnal risk.
Aw dɛn kin no se pɔsin gɛt lukimiya?
Bɔku tɛm, we yu de du blɔd tɛst ɔltɛm, dat kin mek yu dɔktɔ no fɔs se yu go gɛt wan sik we de ambɔg yu ɔ we nɔ de mɛn, ɛn dis kin mek dɛn du mɔ fɔ no mɔ bɔt di sik. If yu de gɛt sɔm sayn dɛn, yu dɔktɔ go tɛl yu fɔ du sɔm tɛst dɛn.
Di we aw dɛn kin no di sik kin inklud:
- Fɔ chɛk yu bɔdi : Yu dɔktɔ go tɔk bɔt yu sik dɛn ɛn chɛk yu fɔ si if yu gɛt sayn dɛn lɛk we di limf no dɛn dɔn swel, di splin ɔ liva we dɔn big, ɔ we blɔd de kɔmɔt na yu gam. Dɛn go chɛk yu skin bak fɔ si if yu gɛt rash, lɛk petechiae.
- Kɔmplit Blɔd Kɔnt (CBC) : Dis tɛst de mek yu dɔktɔ ebul fɔ chɛk yu rɛd blɔd sɛl, wayt blɔd sɛl, ɛn pletlɛt kɔnt. If yu gɛt lukimiya, bɔku tɛm yu wayt blɔd sɛl dɛn kin bɔku pas aw i kin bi.
- Blɔd sɛl ɛgzamin : Yu dɔktɔ kin ɔda fɔ du ɔda tɛst, lɛk flɔ saytometri ɔ fɔ smɛl blɔd na di say we yu de, fɔ luk fɔ patikyula mak dɛn fɔ di lukimiya sɛl dɛn.
- Bone marrow biopsy or aspiration : If yu blɔd nɔ de wok fayn, yu dɔktɔ kin du dis tɛst. Dɛn kin put wan lɔng nidul insay yu bon (bɔku tɛm na di hip bon) fɔ gɛda wan likwid sɛmpul. Dɔn di lab kin chɛk dis sampul fɔ lukimiya sɛl fɔ kɔnfɔm di diagnosis ɛn no di pasɛnt pan di abnɔmal sɛl dɛn na yu bon mɛro.
- Imej ɛn ɔda tɛst dɛn : If yu sik sho se di lukimiya dɔn afɛkt yu bon, ɔgan, ɔ tisu, yu dɔktɔ kin ɔda fɔ mek dɛn tek ɛkstrem rayt na yu chɛst, CT skan, ɔ MRI. Duya notis se di lukimiya sɛl dɛnsɛf nɔ kin si pan dɛn imej tɛst ya.
- Lumbar pancture (spinal tap) : Yu dɔktɔ kin gɛda wan sɛmpul pan spɛshal wata fɔ no if lukimiya dɔn spre to di wata we de rawnd yu bren ɛn spɛshal kɔd.
Aw dɛn kin trit lukimiya?
Di tritmɛnt fɔ lukimiya dipen pan di kayn we aw yu gɛt, yu ej, yu ɔl wɛl bɔdi, ɛn if di kansa dɔn skata to ɔda ɔgan ɔ tisu dɛm.
Bɔku tɛm, yu mɛdikal tim na Nirogi Lanka kin yuz wan ɔ wan pan dɛn tritmɛnt ya:
- Kimotɛrapi : Dis na di kayn tritmɛnt we dɛn kin yuz fɔ mɛn lukimiya. I de yuz pawaful mɛrɛsin fɔ pwɛl di lukimiya sɛl dɛn ɔ fɔ stɔp dɛn fɔ sheb. Dipen pan yu spesifik protɔkɔl, yu kin gɛt dɛn drɔgs ya bay yu mɔt, bay we yu de infuz yu na yu bɛlɛ, ɔ tru injɛkshɔn ɔnda di skin. Bɔku tɛm, dɛn kin yuz bɔku kemotɛrapi mɛrɛsin dɛn togɛda fɔ mek shɔ se dɛn gɛt di bɛst tin fɔ du.
- Immunotherapy (biologic therapy) : Dis tritmɛnt de gi yu bɔdi in natura difɛns sistɛm—yu imyun sistɛm—fɔ aktiv wan fɔ fɛt lukimiya. Dɛn spɛshal drɔgs ya de ɛp yu imyun sistɛm fɔ no di kansa sɛl dɛn fayn fayn wan ɛn mek di imyun sɛl dɛn prodyuz fɔ pul dɛn kɔmɔt.
- Targeted therapy : Dis we fɔ du tin de yuz mɛrɛsin dɛn we dɛn mek spɛshal fɔ atak di say dɛn we di lukimiya sɛl dɛn nɔ gɛt bɛtɛ wɛlbɔdi, lɛk sɔm patikyula prɔtin ɔ jin dɛn we de alaw dɛn fɔ pas di blɔd sɛl dɛn we gɛt wɛlbɔdi. We dɛn drɔgs ya de tɔch dɛn patikyula tin ya, dɛn kin stɔp di sɛl dɛn fɔ sheb, kɔt dɛn blɔd, ɔ pwɛl dɛn dairekt wan, bɔku tɛm dɛn nɔ kin pwɛl di sɛl dɛn we gɛt wɛlbɔdi. εgzampl dεm na di mכnoklonal antibodi dεm εn di tayrosin kinaz inhibito dεm.
- Radiation therapy : Dis tritmɛnt de yuz bim ɔ X-ray we gɛt bɔku ɛnaji fɔ pwɛl di lukimiya sɛl dɛn ɔ fɔ mek dɛn nɔ gro. We dɛn de du di tritmɛnt, dɛn kin pe atɛnshɔn mɔ pan sɔm patikyula say dɛn usay di kansa sɛl dɛn kin bɔku, ɔ i kin de na di wan ol bɔdi, ɛn sɔntɛnde dɛn kin yuz dis fɔ pripia fɔ transplant stem sɛl.
- Hematopoietic cell transplant (stem cell or bone marrow transplant) : Insay dis prosidur, di sik, we de mek lukimiya—we bɔku tɛm dɛn kin was am wit ay doz kemotɛrapi ɔ raytin—dɛn kin tek nyu stem sɛl dɛn we gɛt wɛlbɔdi. Dɛn sɛl ya kin bi yu yon (we dɛn kin gɛda bifo dɛn trit yu) ɔ dɛn kin kɔmɔt frɔm pɔsin we gi yu. we dεn transplant dεn hεlth sεl dεm ya de bכku εn bigin fכ mek nכmal bon mכro εn blכd sεl dεm (rεd bכdi sεl dεm, wayt blכd sεl dεm, εn pletlεt dεm).
- Chimeric Antigen Receptor (CAR) T-cell therapy : Dis na advans tritmɛnt we dɛn kin yuz. I min fɔ gɛda yu yon T-sɛl dɛn—we na wan kayn imyun sɛl we rili impɔtant fɔ fɛt infɛkshɔn—ɛn fɔ mek dɛn jɛnɛtiks na lab fɔ no ɛn atak yu patikyula lukimiya sɛl dɛn bifo yu put dɛn bak na yu blɔd.
Yu kin gɛt di chans bak fɔ tek pat pan klinik trial , we de tɛst di laytst ɛkspirimɛnt kansa tritmɛnt dɛm. Mek shɔ se yu tɔk to yu dɔktɔ bɔt di bɛnifit ɛn prɔblɛm dɛn we kin apin we dɛn du dɛn kayn tray ya.
Wetin na di pat dɛm fɔ trit lukimiya?
Dipen pan yu tritmɛnt plan, yu joyn kin involv fɔ kɔntinyu fɔ du am ɔr dɛn kin sheb am to difrɛn pat dɛm. Tipikli, tritmεnt kin strכkchכ to tri stej, εvri wan gεt wan spεshal gol:
1. Indukshɔn tɛrapi : Di men gol ya na fɔ pwɛl bɔku lukimiya sɛl dɛn na yu blɔd ɛn bon mɛro as yu ebul fɔ mek yu gɛt rɛmishɔn . We yu blɔd de rɛdi, yu blɔd kin kam bak to nɔmal, yu nɔ kin no di lukimiya sɛl dɛn, ɛn di sayn ɛn sayn dɛm fɔ di sik kin dɔn. Indukshɔn tɛrapi kin tek lɛk 4 to 6 wiks.
2. Kɔnsolidɛshɔn tɛrapi (dɛn kin kɔl am bak intensifikɛshɔn) : Di gol fɔ dis pat na fɔ pul ɛni lukimiya sɛl we lɛf, we dɛn nɔ go ebul fɔ no fɔ mek di kansa nɔ kam bak. Dɛn kin gi dis tritmɛnt insay saykl dɛn fɔ 4 to siks mɔnt.
3. Mentɛnans tɛrapi : Dis pat de aim fɔ pwɛl ɛni rɛsɛdyual lukimiya sɛl we kin dɔn liv di stej dɛn we bin dɔn pas, we go ridyus di risk fɔ mek i kam bak . Dis pat kin kɔntinyu fɔ tu ia.
If lukimiya kam bak, yu dɔktɔ go gayd yu fɔ bigin ɔ ajɔst yu tritmɛnt plan bak.
Wetin na di tin we dɛn kin tink se go apin afta dɛn dɔn no se pɔsin gɛt lukimiya?
Fɔ no wan patikyula prɔgnosis na kɔmpleks, bikɔs ɔlman in joyn na in yon. Di we aw yu de si tin dipen pan sɔm impɔtant tin dɛn:
- jεnεtik abnכmaliti כ mכtεshכn : Di spεsifi k mכtεshכn dεm we dεn fכnshכn insay yu lukimiya sεl dεm na dεn mכst imכtant indikεtכ dεm fכ yu prכgnosis.
- Tayp fɔ lukimiya : Sɔm kayn lukimiya kin ansa fayn to tritmɛnt pas ɔda wan dɛn.
- di bכdi sεl kכnt dεm we dεn no di sik : Di nכmba fכ di lukimiya sεl dεm we de we dεn fכs no yu de ple wan rol.
- Ej : Jɛnɛral wan, yɔŋ pipul dɛn kin gɛt mɔ fayn tin fɔ du.
- Jɛnɛral wɛlbɔdi : Yu ɔl bɔdi wɛl bɔdi ɛn fitnɛs we yu gɛt di tɛm we dɛn no di sik kin afɛkt aw yu go wɛl.
- Rispɔns to tritmɛnt : Aw kwik yu kin gɛt remission de gi yu impɔtant tin fɔ no bɔt aw yu tritmɛnt go wok fayn.
- di prεsεns fכ lukimiya na di sεntri nεv sεstem : If dεn fכn lukimiya sεl dεm na yu spεnal fכluid, dis nid fכ mכr spεshal tritmεnt.
Fɔ dɔn, yu dɔktɔ na Nirogi Lanka na di bɛst pɔsin fɔ ɛp yu fɔ ɔndastand wetin dɛn tin ya min fɔ yu spɛshal wan. Nɔ shek fɔ aks dɛn bɔt yu prɔgnosis.
Yu tink se lukimiya kin mɛn?
Pan ɔl we dɛn nɔ kin yuz di wɔd “cure” fɔ di kɔntɛks fɔ lukimiya, bɔku pasɛnt dɛn kin ebul fɔ gɛt di sik fɔ lɔng tɛm . Wan mɛrɛsin go min se di kansa dɔn go sote go ɛn i nɔ go ɛva kam bak; bɔt, we dɛn tink bɔt di kayn lukimiya, bɔku tɛm dɔktɔ dɛn kin pe atɛnshɔn pan di we aw di sik nɔ de sote go.
Lɔng tɛm rɛmishɔn min se nɔr sayn nɔr de fɔ no bɔt kansa, wit ɔr nɔr de kɔntinyu fɔ gɛt tritmɛnt. Dis rεmishכn kin las fכ ia, εn fכ bכku pipul dεm, di lukimiya kin nכ go εva kam bak. If i kam bak, yu mɛdikal tim go rɛdi fɔ tɛl yu nyu tritmɛnt dɛn fɔ mek yu ebul fɔ kɔntrol am bak.
Di bɛst pɔsin fɔ tɔk bɔt yu patikyula sityueshɔn na yu wɛlbɔdi tim; dɛn go wach aw yu de go bifo gud gud wan ɛn mek yu kia plan fɔ wetin yu nid.
Us kwɛstyɔn dɛn yu fɔ aks yu dɔktɔ?
Fɔ no na pawaful tin. If yu ɔndastand aw yu gɛt di sik ɛn aw fɔ trit yu, dat go ɛp yu fɔ fil se yu ebul fɔ kɔntrol yusɛf mɔ. I fayn fɔ rayt yu kwɛstyɔn dɛn bifo yu apɔntin ɛn if i pɔsibul, kam wit yu padi ɔ fambul fɔ sɔpɔt yu.
Sɔm kwɛstyɔn dɛn we yu fɔ tink bɔt fɔ aks:
- Us patikyula kayn lukimiya a gɛt, ɛn us kayn sɛl i kɔmɔt frɔm? Dis na fɔm we de fɛt ɔ we de gro sloslo?
- Aw di lukimiya bin dɔn go bifo we dɛn bin no se i gɛt?
- Wetin na di tritmɛnt dɛn we a kin gɛt?
- Wetin na di patikyula bɛnifit ɛn risk dɛm fɔ ɛni tritmɛnt we dɛn kin gɛt?
- Us tritmɛnt plan dɛn kin advays mi, ɛn wetin mek?
- Ustɛm fɔ bigin tritmɛnt?
- Aw lɔŋ di tritmɛnt (ɛn ɛni pat) go las?
- A go nid fɔ de na ɔspitul, ɛn if na so, fɔ aw lɔng?
- Wetin na di sayd ɛfɛkt dɛm, ɛn wetin dɛn kin du fɔ mek dɛn nɔ gɛt am ɔ fɔ mɛn dɛn?
- If a want fɔ bɔn pikin tumara bambay, wetin na di tin dɛn we a kin du fɔ mek a nɔ ebul fɔ bɔn pikin ?
- Wetin na di sakses rεt ɔr sɔvayv rεt fɔ mi patikyula kayn lukimiya?
- A fɔ tink bɔt fɔ tek pat pan klinik trial ?
Usay yu kin fɛn ɔda infɔmeshɔn ɛn sɔpɔt bɔt lukimiya?
Fɔ no mɔ bɔt klinik trial fɔ lukimiya, yu kin go to intanashɔnal risɔs lɛk di Lukimia & Limfoma Sɔsayti, di Nashɔnal Kɛnsa Instityut, ɛn di Amɛrikan Kɛnsa Sɔsayti. Apat frɔm dat, duya aks yu wɛlbɔdi prɔvayda bɔt di lokal sɔpɔt grup ɛn di tin dɛn we de na yu eria.
Fɔ gɛt ɛni kansa we dɛn no se yu gɛt kansa kin mek yu fred, bɔt if yu no se yu gɛt lukimiya, i kin rili fil bad. Bikɔs no sɔlid tumbu nɔ de fɔ pul, i kin at fɔ imajin aw yu tritmɛnt rod ɛn tumara bambay go tan lɛk. Duya mɛmba se lukimiya nɔto wan sik we gɛt fiks autkam. Yu tritmɛnt joyn ɛn de chans fɔ mek yu gɛt rɛmishɔn fɔ lɔng tɛm dipen pan bɔku spɛshal tin dɛm. Nɔbɔdi nɔ go ebul fɔ tɔk kɔrɛkt wan bɔt yu patikyula rod if yu nɔ ɔndastand yu wɛlbɔdi ɛn di patikyula kwaliti dɛn we yu lukimiya sɛl dɛn gɛt. Wi de ɛnkɔrej yu fɔ tɔk to yu dɔktɔ opin wan ɛn ɔnɛs bɔt wetin dis diagnosis min fɔ yu.
Ki tin dɛn we dɛn kin tek fɔ tek
Wi op se dis infɔmeshɔn dɔn mek yu ɔndastand klia wan bɔt lukimiya. Na di impɔtant pɔynt dɛn we yu fɔ mɛmba:
- Lukimia na kansa na di blɔd we kin apin we di nɔmal sɛl dɛn na di bon mɛrɔ kin bɔku we pɔsin nɔ ebul fɔ kɔntrol.
- di praymar tכp dεm dεn kכl dεm as akyu כ krכnik , εn bak mayloid כ lymphoid .
- Di sayn dɛm kin difrɛn, bɔt kin bi wae yu taya pasmak, yu kin gɛt infekshɔn ɔltɛm, ɛn yu kin gɛt brus ɔ blɔd izi wan .
- Pan ɔl we bɔku tɛm dɛn nɔ kin no di rayt tin we kin mek pɔsin gɛt kansa, dɛn no se di tin dɛn we kin mek pɔsin chenj in jɛnɛtiks, we pɔsin kin gɛt sɔm kemikal dɛn, ɛn di tritmɛnt dɛn we i bin dɔn gɛt bifo tɛm fɔ mek i gɛt kansa .
- Dɛn kin no di sik mɔ bay we dɛn de du blɔd tɛst ɛn bon mɛro bayɔpsi .
- Bɔrku tritmɛnt de fɔ yu (lɛk kemotɛrapi, imyunotɛrapi, ɛn targeted therapy), wae dɛn mek fɔ yu ɛn yu sik prɔfayl.
- Bifo yu pe atɛnshɔn pan wan mɛrɛsin we go de ɔlsay na di wɔl, bɔku tɛm di gol na fɔ mek dɛn nɔ gɛt di sik fɔ lɔng tɛm .
- Nɔ ɛva shem fɔ aks yu dɔktɔ kwɛstyɔn dɛn ɛn aks fɔ mek dɛn no klia wan. Yu no de yu wan fo dis joyn wit Nirogi Lanka.
Wi op se yu dɔn si se dis infɔmeshɔn go ɛp yu. Stay strɔng ɛn tek kia ɔf yu wɛlbɔdi!
Ki wɔd dɛm: lukimiya, blɔd kansa, bon mɛro, blɔd sɛl dɛm, di sayn dɛm fɔ lukimiya, lukimiya tritmɛnt dɛm
